Latest Articles

Publication Date
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report - Cureus

Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report Cureus

Published: Oct. 27, 2024, 7:49 a.m.
When Menstruation Meets the Pleura: A Rare Case of Catamenial Hemothorax and Thoracic Endometriosis and a Literature Review.

Catamenial hemothorax is a rare manifestation of thoracic endometriosis, characterized by blood in the pleural cavity associated with menstrual cycles. We present the case of a 42-year-old woman with recurrent …

Published: Oct. 27, 2024, midnight
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - The Week

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation The Week

Published: Oct. 25, 2024, 5:28 a.m.
Natural compounds for endometriosis and related chronic pelvic pain: A review.

Endometriosis is a chronic gynecological disorder characterized by significant chronic pelvic pain (CPP) and infertility, adversely affecting the quality of life for many women worldwide. This review aims to synthesize …

Published: Oct. 25, 2024, midnight
Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma

Published: Oct. 24, 2024, 9:31 p.m.
Chemotherapy Combinations and the Phase 3 DUO-E Trial - Cancer Network

Chemotherapy Combinations and the Phase 3 DUO-E Trial Cancer Network

Published: Oct. 24, 2024, 6:32 p.m.
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape

Published: Oct. 24, 2024, 1:44 p.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.
N-acetylcysteine Clinical Applications.

This study aims to evaluate the therapeutic application of N-acetylcysteine (NAC) as a treatment or adjunct therapy for various medical conditions. While its efficacy in treating acetaminophen overdose, cystic fibrosis, …

Published: Oct. 24, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!